ReviewFrontiers in immunology2023
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
Jérôme de Sèze et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
96 papers cite itlatest 60 shown
this paperpooled ittrialcites it